Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06089304 · ClinicalTrials.gov registry record
Patient Centered Machine Learning Model for Bleeding and Ischemic Risk
A clinical trial of Coronary Artery Disease and Percutaneous Coronary Intervention, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 19,000
- Enrollment target
- 1
- Study location
NCT06089304 is a study of Coronary Artery Disease and Percutaneous Coronary Intervention that has completed, run by Abbott Medical Devices. The registered enrollment target is 19,000 participants, above the 1,200-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1483% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06089304, a study of Coronary Artery Disease and Percutaneous Coronary Intervention, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 19,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Dual antiplatelet therapy (DAPT) is indicated in all patients undergoing coronary stent implantation to prevent ischemic recurrencies despite an increased risk of bleeding. Accordingly, clinical practice guidelines advocate tailoring DAPT duration according to the patient's individual ischemic and bleeding risk profile. Data from 11 clinical trials involving patients who underwent percutaneous coronary intervention (PCI) with an everolimus-eluting stent will be pooled and analyzed to develop a machine learning-based algorithm to predict the probability of an ischemic or bleeding event up to 1 year. These predictive risk models aim to support clinical decision-making on DAPT management after PCI.
Conditions Studied
Interventions
- DEVICE Percutaneous coronary intervention
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,000 participants |
| Start Date | 2008-05 |
| Est. Completion | 2023-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06089304
The ClinicalTrials.gov registry entry for NCT06089304 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,200-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1483% higher). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Percutaneous coronary intervention is the first listed.
NCT06089304 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06089304 about?
NCT06089304 is a clinical study titled "Patient Centered Machine Learning Model for Bleeding and Ischemic Risk". Dual antiplatelet therapy (DAPT) is indicated in all patients undergoing coronary stent implantation to prevent ischemic recurrencies despite an increased risk of bleeding. Accordingly, clinical practice guidelines advocate tailoring DAPT duration according to the patient's individual ischemic and b...
What is the current status of trial NCT06089304?
This trial is currently completed. The enrollment target is 19,000 participants. The study started on 2008-05. Estimated completion is 2023-10.
What conditions does trial NCT06089304 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Percutaneous Coronary Intervention.
What interventions are being tested in trial NCT06089304?
The interventions under investigation include: Percutaneous coronary intervention (DEVICE).
Who is sponsoring clinical trial NCT06089304?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06089304 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.